ArticleCurrent microbiology2021
Bioleaching Studies of Uranium in a Rock Sample from Sinai Using Some Native Streptomyces and Aspergillus Species.
Article in Current microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioleaching of uranium from ores and rocks using filamentous fungi.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sinai's important geographical and strategic position is attracting researchers to explore opportunities to maximize exploitation of its treasures, especially in the area of sustainable development. One of the fields of exploitation is extracting valuable metals from low-grade ores using green technologies. In this study, we examined the possibility of microbial leaching of uranium (U) from a rock sample collected from Wadi Naseib, Sinai, Egypt. Twenty previously isolated and tentatively identified native microorganisms, 10 Streptomyces and 10 Aspergillus, were used to make U-bioleaching using cells (direct) and cell metabolites (indirect). The tested isolates showed variable U-bioleaching efficiencies and the highest results was attained via the indirect method (57.2 ± 9.2% and 83.6 ± 2.3%) using two isolates that were identified genotypically as Streptomyces sp. EGY1 and Aspergillus niveus EGY2 respectively. TEM images showed that cells of A. niveus EGY2 made biomineralization, biosorption and bioaccumulation of U. The present study revealed that neither high acid production nor high phosphatase activities guarantees a high U-bioleaching efficiency. Many factors affecting the process were also studied using A. niveus EGY2. The highest U-bioleaching efficiency (87.8 ± 8.7%) was attained using pH 9, 160 rpm of both culturing and bioleaching steps, rock particle size of above 700 µm and 1% pulp density. U was recovered from leach liquor after optimization experiments using NaOH and its concentration was 64.35%. Our study revealed that Aspergillus niveus EGY2 could be promising in future scaling-up studies and pilot trials using the tested rock sample.
Indexed as
Identifiers
33392668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.